<i>In Vivo</i> and <i>in Vitro</i> Evaluation of the Anti-Diabetic Activity of Chemically Analyzed <i>Abelmoschus esculentus</i> Extracts

Background Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia and associated complications. Natural plant-based therapies have gained increasing attention due to their potential efficacy and safety. Abelmoschus esculentus (AE) has traditionally been used for the management of diabetes; however, its anti-diabetic mechanisms require further scientific validation. Objective This study aimed to chemically characterize of AE fruit methanol (AEM), hexane (AEH), and water (AEW) extracts and evaluate their anti-diabetic activity using both in vitro and in vivo experimental models. Methods AE extracts were prepared and chemically analyzed using standard phytochemical and GC/MS analysis. In vitro anti-diabetic activity was assessed through testing glucose transporter-4 (GLUT4) translocation to the plasma membrane (PM) in a rat muscle cell line stably expressing myc-tagged GLUT4 (L6-GLUT4myc) using enzyme-linked immunosorbent assay. Antioxidant activity also performed by 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay. In vivo anti-diabetic effects were evaluated in experimentally induced diabetic animal models by monitoring blood glucose levels. Results GC-MS analysis identified 14 compounds in the AEM and 12 in the AEH known to possess anti-diabetic activity. AEM and AEH enhanced GLUT4 translocation in L6-GLUT4myc muscle cells, with AEM showing the highest activity. Oral AEM treatment reduced blood glucose levels in diabetic mice from 525 ± 46 to 234 ± 56 mg/dL after 5 weeks. Both extracts exhibited antioxidant activity, with AEM achieving 69% inhibition in the DPPH assay. Conclusion The findings demonstrate that chemically characterized AE extracts possess significant anti-diabetic activity in both in vitro and in vivo models. These effects may be attributed to the presence of bioactive phytochemicals that improve glucose metabolism.AE may therefore represent a promising natural therapeutic candidate for the management of diabetes mellitus.

Authors

Institutions

Publication Details

Journal
Natural Product Communications
Published
2026-03-01
DOI
https://doi.org/10.1177/1934578x261433112
Primary Topic
Agricultural Practices and Plant Genetics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

In Vivo and in Vitro Evaluation of the Anti-Diabetic Activity of Chemically Analyzed Abelmoschus esculentus Extracts

Najlaa Bassalat, Sébastien Blaise, Hilal Zaid, Zipora Tietel et al.
Natural Product Communications
Agricultural Practices and Plant Genetics
article

In Vivo and in Vitro Evaluation of the Anti-Diabetic Activity of Chemically Analyzed Abelmoschus esculentus Extracts

Najlaa Bassalat, Sébastien Blaise, Hilal Zaid, Zipora Tietel, Sleman Kadan, Hazim Alsharabaty, Zain Abu Arra, Sarit Melamed, Zaid Zaid, Waseim Barriah
article en

Abstract

Background Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia and associated complications. Natural plant-based therapies have gained increasing attention due to their potential efficacy and safety. Abelmoschus esculentus (AE) has traditionally been used for the management of diabetes; however, its anti-diabetic mechanisms require further scientific validation. Objective This study aimed to chemically characterize of AE fruit methanol (AEM), hexane (AEH), and water (AEW) extracts and evaluate their anti-diabetic activity using both in vitro and in vivo experimental models. Methods AE extracts were prepared and chemically analyzed using standard phytochemical and GC/MS analysis. In vitro anti-diabetic activity was assessed through testing glucose transporter-4 (GLUT4) translocation to the plasma membrane (PM) in a rat muscle cell line stably expressing myc-tagged GLUT4 (L6-GLUT4myc) using enzyme-linked immunosorbent assay. Antioxidant activity also performed by 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay. In vivo anti-diabetic effects were evaluated in experimentally induced diabetic animal models by monitoring blood glucose levels. Results GC-MS analysis identified 14 compounds in the AEM and 12 in the AEH known to possess anti-diabetic activity. AEM and AEH enhanced GLUT4 translocation in L6-GLUT4myc muscle cells, with AEM showing the highest activity. Oral AEM treatment reduced blood glucose levels in diabetic mice from 525 ± 46 to 234 ± 56 mg/dL after 5 weeks. Both extracts exhibited antioxidant activity, with AEM achieving 69% inhibition in the DPPH assay. Conclusion The findings demonstrate that chemically characterized AE extracts possess significant anti-diabetic activity in both in vitro and in vivo models. These effects may be attributed to the presence of bioactive phytochemicals that improve glucose metabolism.AE may therefore represent a promising natural therapeutic candidate for the management of diabetes mellitus.

Natural Product CommunicationsVol. 21(3)
Arab American University (PS), Université de Reims Champagne-Ardenne (FR)
Good health and well-being
Openalex Percentile: Top 6%
Agricultural Practices and Plant Genetics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.